These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15284864)

  • 1. Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes.
    Ma L; Delforge M; van Duppen V; Verhoef G; Emanuel B; Boogaerts M; Hagemeijer A; Vandenberghe P
    Leukemia; 2004 Sep; 18(9):1451-6. PubMed ID: 15284864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood.
    Ma L; Scheers W; Vandenberghe P
    J Immunol Methods; 2004 Feb; 285(2):215-21. PubMed ID: 14980435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores J; Bárcena P; Rasillo A; Sayagues JM; Sánchez ML; Hernandez-Campo P; Hernandez Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Orfao A
    Leukemia; 2008 Jun; 22(6):1175-83. PubMed ID: 18337765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Rigolin GM; Rosti V; Bonetti E; Travaglino E; Boveri E; Gallì A; Boggi S; Ciccone M; Pramparo T; Mazzini G; Invernizzi R; Lazzarino M; Cazzola M
    Leukemia; 2008 Mar; 22(3):530-7. PubMed ID: 18094717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
    Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
    Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
    van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
    Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.
    Cutler JA; Wells DA; van de Loosdrecht AA; de Baca ME; Kalnoski MH; Zehentner BK; Eidenschink L; Ghirardelli KM; Biggerstaff JS; Loken MR
    Cytometry B Clin Cytom; 2011 May; 80(3):150-7. PubMed ID: 21520402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].
    Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Qian L; Yang T; Yang C; Feng B
    Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):80-3. PubMed ID: 15622783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of immunophenotypic abnormalities of bone marrow myeloid cell compartment in myelodysplastic syndromes.
    Marisavljevic D; Kraguljac-Kurtovic N
    J BUON; 2010; 15(4):746-52. PubMed ID: 21229640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological implications of circulating CD34(+) cells in myelodysplastic syndromes.
    Marisavljevic D; Kraguljac-Kurtovic N
    J BUON; 2010; 15(4):753-7. PubMed ID: 21229641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
    Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
    Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
    Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
    Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes.
    Kim M; Chung S; See CJ; Yoon SS; Kim BK; Kim HK; Lee DS
    Leuk Res; 2012 Feb; 36(2):163-8. PubMed ID: 21920602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
    Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
    Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders.
    Baurmann H; Cherif D; Berger R
    Leukemia; 1993 Mar; 7(3):384-91. PubMed ID: 8445944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality in myelodysplastic syndromes.
    Weimar IS; Bourhis JH; De Gast GC; Gerritsen WR
    Leuk Lymphoma; 1994 Apr; 13(3-4):215-21. PubMed ID: 7914126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.